2Angulo P. Nonalcoholic fatty liver disease[J].Revista de Gastroenterologia de Mexico,2005,(Suppl 3):52-56.
3Siddiqi F,Carter L,Peltekian KM. Diabetes mellitis:risk factor for advanced liver disease[J].Canadian Medical Association Journal,2011.586.
4Harrison SA. Liver disease in patients with diabetes mellitus[J].Journal of Clinical Gastroenterology,2006.68-76.
5Farrell GC,Chitturi S,Lau GK. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region:executive summary[J].Journal of Gastroenterology and Hepatology,2007.775-777.
6Browning JD,Szezepaniak LS,Dobbins R. Prevalence of the hepatic steatosis in an urban population in the united states:impact of ethnicity[J].Hepatology,2004.1387-1395.
7Forlani G,Di Bonito P,Mannucci E. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome[J].Journal of Endocrinological Investigation,2008.146-152.
8Morling JR,Strachan MW,Hayes PC. Prevalence of abnormal plasma liver enzymes in older people with Type 2 diabetes[J].Diabetic Medicine,2012.488-491.
9Banderas DZ,Escobedo J,Gonzalez E. γ-Glutamyl transferase:a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome[J].European Journal of Gastroenterology and Hepatology,2012.805-810.
10Schindhelm RK,Diamant M,Dekker JM. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease[J].Diabetes/Metabolism Research and Review,2006.437-443.
